Testing anti‐HIV activity of antiretroviral agents in vitro using flow cytometry analysis of CEM‐GFP cells infected with transfection‐derived HIV‐1 NL4‐3

Abstract

An assay, specifically optimized to evaluate the anti-HIV activity of antiretrovirals by flow cytometry analysis, is described. As widely used anti-HIV agents, zidovudine (AZT), abacavir (ABC), 2',3'-dideoxyinosine (DDI), lamivudine (3TC), nevirapine (NVP), and efavirenz (EFV), and as drugs of recent approval raltegravir (RAL), etravirine (ETR), and rilpivirine (RPV), were utilized as reference drugs. HIV-1 NL4-3 virus was prepared by transfection of HEK293T cells with purified plasmid DNA and quantified by p24 antigen-capture assay. For infection, CEM-GFP cells were exposed to vehicle or to several concentrations of the drugs for 2 hr at 37 °C before HIV-1 NL4-3 was added to each sample. The adsorption was prolonged for 3 hr at 37 °C. After 72 hr of incubation, HIV-induced GFP expression in infected CEM-GFP cells was assessed by flow cytometry analysis and expressed as % positive cells. For comparison, p24 production in supernatants was assessed by a commercial ELISA kit. On the basis of IC50 values, the anti-HIV activity, as assayed by this method, was EFV > 3TC > AZT > NVP > DDI > ABC and ETR > RPV > RAL. The comparison between the IC50 values calculated through flow cytometry and p24 production revealed overlapping results, showing that the optimized protocol of CEM-GFP infection with HIV NL4-3 is a suitable method to perform quantitative, rapid and low-expensive screening tests to evaluate the in vitro effect of new candidate anti-HIV drugs.

Do Antiretroviral Drugs Protect From Multiple Sclerosis by Inhibiting Expression of MS-Associated Retrovirus?

“…At day 3, the medium was changed, and fresh drugs were added. The range of different doses was chosen based on datasheet indication and previous publications where similar tests in vitro were used to test antiretroviral efficacy against HIV (20, 21) or porcine endogenous retroviruses (22).…”

Pyrimidine 2,4-Diones in the Design of New HIV RT Inhibitors

“…The antiretroviral activity of all the synthesized compounds was tested by a cell-free RT inhibitory assay, in dose-response fashion [64,65,66]. In particular, the RT inhibitory activity of the new compounds along with that of the reference antiviral compound, NVP, were tested versus HIV-1 or avian myeloblastosis virus (AMV) reverse transcriptase.…”

“…We then focused our attention on compounds ( 6a – c ) to check whether they directly inhibited HIV infection, through a recently developed cell infection assay [65]. For comparison, compound 6g and NVP were also assayed.…”

Effects of Complement Opsonization of HIV on Dendritic Cells: and Implications for the Immune Response

“…AZT is still clinically used today. In addition, AZT is widely used as a means of efficiently inhibiting HIV replication in vitro [11], including by our group.…”